HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
In This Section

Dr. Pinney investigates the molecular mechanisms that link an adverse intrauterine milieu to the development of diabetes and obesity later in life. Specifically, she is researching how intrauterine growth restriction, gestational diabetes and in utero exposure to environmental toxicants contribute to the development of diabetes and obesity in offspring.
Bio
Dr. Pinney's research focuses on the molecular mechanisms linking adverse intrauterine milieu to diabetes and obesity. She is investigating how intrauterine growth restriction, gestational diabetes and in utero exposure to environmental toxicants like bisphenol A, bisphenol S, and perfluorooctanoic acid contribute to the development of diabetes and obesity in offspring.
She performs studies with human samples, animal models, and cell culture systems to understand the mechanisms responsible for fetal programming of childhood and adult metabolic disease.
In addition, Dr. Pinney is identifying and treating children with atypical forms of diabetes, with the aim to develop targeted novel treatments for this population. Along with her colleagues in the Diabetes Center for Children at CHOP, she has identified and treated children and adolescents with 12 different forms of monogenic diabetes. Her lab is actively working to better understand the clinical features and molecular mechanisms responsible for these rare forms of diabetes in children in order to develop novel treatment strategies to benefit all patients with diabetes.
Among her notable accomplishments, Dr. Pinney:
- Measured concentrations of the endocrine disruptor BPA in human amniotic fluid, and reported that amniotic fluid BPA concentrations are associated with decreased birth weight
- Correlated amniotic fluid BPA concentrations with genome wide DNA methylation patterns and gene expression profiles via RNA-Seq in corresponding amniocytes and found that male offspring are more affected by in utero BPA exposure than female offspring
- Characterized the metabolome, transcriptome, and methylome of second trimester amniotic fluid and term placenta exposed to gestational diabetes
- Made the seminal observation that intrauterine growth restriction-induced epigenetic modifications can be reversed by Exendin-4, thereby normalizing the phenotype
- Described a new form of monogenic diabetes due to a recessive mutation in Neurogenin-3 and a novel form of dominant congenital hyperinsulinism that maps to chromosome 10q21 at the Hexokinase 1 locus
Education and Training
BA, University of Pennsylvania (History of Art), 1996
MD, University of Cincinnati College of Medicine, 2002
MS, Perelman School of Medicine, University of Pennsylvania (Translational Research), 2010
Titles and Academic Titles
Attending Physician
Assistant Professor of Pediatrics
Professional Memberships
Pediatric Endocrine Society, 2005-
The Endocrine Society, 2006-
American Diabetes Association, 2006-
Philadelphia Endocrine Society, 2006
Pediatric Endocrine Society, 2008-
Professional Awards
Outstanding Basic Science Research Presentation, Outstanding Patient-Oriented Research Presentation, University of Pennsylvania Institute of Diabetes, Obesity and Metabolism Research Symposium, 2007
Basic Science Award, University of Pennsylvania Center for Research in Reproduction and Women’s Health Research, 2007
Lilly/Lawson Wilkins Pediatric Endocrine Society Research Fellowship, 2007
University of Pennsylvania Institute of Translational Medicine and Therapeutics Fellowship, 2007
Lawson Wilkins Pediatric Endocrine Society, Presidential Reception Poster Presentation, 2010
Susan Heyner Award for Excellence in Research, University of Pennsylvania Center for Research in Reproduction and Women’s Health, 2010
Outstanding Patient-Oriented Research Presentation, University of Pennsylvania Institute of Diabetes, Obesity and Metabolism Research Symposium, 2012
Patient-Oriented Research Award, Children's Hospital of Philadelphia, 2016
Patient Oriented Research Presentation Winner, University of Pennsylvania Institute of Diabetes, Obesity and Metabolism Research Symposium, 2016
University of Pennsylvania Center for Excellence in Environmental Toxicology Mentored Scientist Transition Award, 2016
Patient Oriented Research Presentation Winner, University of Pennsylvania Institute of Diabetes, Obesity and Metabolism Research Symposium, 2018